Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder in Japan (PERFORM-J): Protocol for a Prospective Cohort Study (Preprint)
Preprint
- 22 December 2017
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Patients with major depressive disorder may exhibit cognitive dysfunction that can affect functional outcomes. However, the prevalence and burden of cognitive dysfunction in Japanese patients with MDD have not been thoroughly examined. Objective: To investigate the time course (over 6 months) of several functional outcomes during treatment with antidepressants in Japanese patients with major depressive disorder. The primary objective is to assess longitudinal changes in cognitive function and depressive symptoms, using both clinician-rated and patient-rated scales. The study incorporates assessments of cognitive function and other functional outcomes (functional capacity, disability, work productivity and impairments of activity, and quality of life), as well as depressive symptoms. Methods: PERFORM-J (Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder in Japan) is a 6-month, prospective, multi-center, epidemiological cohort study. Participants are Japanese outpatients aged 18-65 years with a recurrent or new diagnosis of a major depressive episode (according to the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision [DSM-IV-TR]), who are initiating a new antidepressant as monotherapy (either as first-line therapy or after switching from a previous antidepressant). Eligible patients are evaluated objectively during four visits (at baseline and at Months 1, 2, and 6) using physician-rated assessments of severity of depressive symptoms, cognitive function, and functional capacity. Subjective, patient-reported, outcomes are also assessed as indicators of depressive symptoms, disability, work productivity or impairments of activity, and perceived cognitive dysfunction. Results: The study began in September 2016. Patient enrollment was completed on June 30, 2017, with 523 patients having been enrolled from 48 study sites. As of October, 2017, 279 patients had completed the study. Conclusions: PERFORM-J is expected to provide valuable information on the longitudinal relationship between cognitive dysfunction, depressive symptoms, and other functional outcomes in Japanese patients with major depressive disorder who initiate monotherapy with antidepressants. Trial Registration: UMIN Clinical Trials Registry UMIN000024320; https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi? recptno=R000028011 (Archived by WebCite at http://www.webcitation.org/70K7W9PgC). Registered Report Identifier: RR1-10.2196/9682Keywords
All Related Versions
- Published version: JMIR Research Protocols, 7 (6), e161.
This publication has 15 references indexed in Scilit:
- Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM studyNeuropsychiatric Disease and Treatment, 2017
- Cognitive dysfunction in major depression and bipolar disorder: Assessment and treatment optionsPsychiatry and Clinical Neurosciences, 2016
- Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: results from the final dataset of World Mental Health Japan SurveyEpidemiology and Psychiatric Sciences, 2015
- Subjective memory and concentration deficits in medication-free, non-elderly Asians with major depressive disorder: Prevalence and their correlatesJournal of Affective Disorders, 2015
- Updates and Trends in the Treatment of Major Depressive DisorderThe Journal of Clinical Psychiatry, 2014
- Cognitive Dysfunction in Major Depressive Disorder: Effects on Psychosocial Functioning and Implications for TreatmentThe Canadian Journal of Psychiatry, 2014
- Is there an association between subjective and objective measures of cognitive function in patients with affective disorders?Nordic Journal of Psychiatry, 2011
- Prevalence of depression and depressive symptoms among older Japanese people: comorbidity of mild cognitive impairment and depressionInternational Journal of Geriatric Psychiatry, 2011
- Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey InitiativeDepression and Anxiety, 2009
- Development of a Brief Scale of Everyday Functioning in Persons with Serious Mental IllnessSchizophrenia Bulletin, 2006